Log in to search using one of your social media accounts:


Novartis received EU approval for drug that treats rare hormonal disorder

Novartis International has announced that it has received approval from the European Commission for its drug called Signifor to treat the rare hormonal disorder acromegaly. HNGN
Source: Society for Endocrinology - Category: Endocrinology Source Type: news

Related Links:

More News: Acromegaly | Endocrinology | Hormones